Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2005
11/08/2005US6962923 Pyrazole compositions
11/08/2005US6962918 Hexahydropyrazino[1'2';1,6]pyrido[3,4-b]indole-1,4-diones for the treatment of cardiovascular disorders and erectile dysfunction
11/08/2005US6962916 For therapy of retrovirus infection
11/08/2005US6962915 Antiinflammatory agents
11/08/2005US6962911 Treatment of impotence, sexual dysfunction in female, stable, unstable and variant angina, hypertension, pulmonary hypertension, congestive heart failure, atherosclerosis
11/08/2005US6962799 Microtubule-associated proteins and tubulins
11/08/2005US6962710 Compounds and methods for immunotherapy and diagnosis of tuberculosis
11/08/2005US6962706 for use in raising immune response against Porphyromonas gingivalis, comprising suitable adjuvant, carrier or excipient and peptide of not more than 50 amino acids including P. gingivalis epitope comprising sequence RYDDFTFEAGKKYTFTMRRAGMGDGTD
11/08/2005US6962694 Cytolysis of target cells by superantigen conjugates inducing T-cell activation
11/08/2005CA2157288C Methods and compositions for inhibition of angiogenesis
11/03/2005WO2005103283A1 Novel method of screening
11/03/2005WO2005103250A1 THERAPEUTIC MEDICINE CONTAINING MONOCLONAL ANTIBODY AGAINST FOLATE RECEPTOR BETA (FR-β)
11/03/2005WO2005103054A2 Bridged piperazine and piperidine derivatives as ccri antagonists
11/03/2005WO2005103030A1 1,4-di substituted benzene compounds, process for preparing the same and use thereof
11/03/2005WO2005103012A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof
11/03/2005WO2005102999A2 Crystalline forms of fexofenadine hydrochloride and processes for their preparation
11/03/2005WO2005102388A1 Novel blt2-mediated disease, and blt2 binding agent and compound
11/03/2005WO2005102369A1 Pharmaceutical preparation containing bacterial cell wall skeleton component
11/03/2005WO2005102313A1 Preventive and/or therapeutic agent for chronic sinusitis
11/03/2005WO2005102302A1 Medicinal preparation
11/03/2005WO2005102291A1 Seamless capsule containing water-soluble active ingredient
11/03/2005US20050245750 Process for preparing 1,3-benzodioxole-2-spirocycloalkane derivative
11/03/2005US20050245731 DNA encoding tumor necrosis factor inhibitory protein and its use
11/03/2005US20050245586 2,5-Dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12
11/03/2005US20050245576 Substituted pyrazoles
11/03/2005US20050245575 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists
11/03/2005US20050245564 Methods and compositions related to IRM compounds and toll-like receptor pathways
11/03/2005US20050245538 Dipeptidyl peptidase inhibitor; antidiabetic agents; obesity; viricides; anticancer agents; oral diseases; autoimmune disease
11/03/2005US20050245537 Use of compounds having ccr antagonism
11/03/2005US20050245522 Novel compounds
11/03/2005US20050245511 Novel compounds that inhibit tryptase activity
11/03/2005US20050245496 Mixture with carrier; dosage units; prevent ovulation; immonomoderator
11/03/2005US20050245493 Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
11/03/2005US20050245488 Pharmaceutically active compounds and methods of use thereof
11/03/2005US20050245467 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
11/03/2005US20050244930 IL-21 antagonists
11/03/2005US20050244915 Assays for modulators of asparaginyl hydroxylase
11/03/2005US20050244888 Antibodies to human chemokine beta-9
11/03/2005US20050244877 Splice variants of CD40-receptor
11/03/2005US20050244812 Kits and methods for detection of apoptotic cells
11/03/2005US20050244526 Use of a preparation produced from plant seedlings, enriched with electrolyte
11/03/2005US20050244425 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
11/03/2005US20050244421 Compositions and methods for modulating immune response
11/03/2005US20050244418 Recombinant tumor specific antibody and use thereof
11/03/2005US20050244412 Method and composition for regulating activity of regulatory T cells
11/03/2005US20050244406 Monoclonal antibodies against extracellular loops of c5ar
11/03/2005US20050244392 Probiotic strains, a process for the selection of them, compositions thereof, and their use
11/03/2005US20050244386 Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
11/03/2005US20050244374 Enveloped miroorganism
11/03/2005CA2564574A1 Use of c-kit inhibitors for treating fibrosis
11/03/2005CA2564180A1 Pharmaceutical preparation containing bacterial cell wall skeleton component
11/03/2005CA2563684A1 Preventive and/or therapeutic agent for chronic sinusitis
11/03/2005CA2563680A1 Seamless capsule containing water-soluble active substance
11/03/2005CA2562764A1 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo
11/03/2005CA2561724A1 Azaindoles useful as inhibitors of rock and other protein kinases
11/03/2005CA2560882A1 Crystalline forms of fexofenadine hydrochloride and processes for their preparation
11/03/2005CA2559917A1 Compounds as ccri antagonists
11/02/2005EP1591529A2 Human CLTA-8 and uses of CTLA-8-related proteins
11/02/2005EP1591444A1 CCR5 antagonists useful for treating aids
11/02/2005EP1591437A2 Interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators
11/02/2005EP1591120A1 Receptor agonists
11/02/2005EP1590431A2 TNF-a BINDING MOLECULES
11/02/2005EP1590372A2 Trimeric polypeptide construct to induce an enduring t cell response
11/02/2005EP1590370A1 Increase of the immune response by substances influencing the function of natural killer cells
11/02/2005EP1590369A2 Human il-1 beta antagonists
11/02/2005EP1590360A1 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases
11/02/2005EP1590334A1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta
11/02/2005EP1590327A1 Ccr8 inhibitors
11/02/2005EP1590321A2 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/02/2005EP1590047A1 Composition comprising lactobacilli or bifidobacteria and use thereof
11/02/2005EP1589990A2 Method for treating cancer in humans
11/02/2005EP1507758B1 Indole derivatives and their use as ligands for cb2 receptors
11/02/2005EP1501833B1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1501525B1 Method for producing preparations rich in tocotrienol
11/02/2005EP1472256B1 Piperidine derivatives
11/02/2005EP1332149B1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
11/02/2005EP1278719B1 Naphthamide neurokinin antagonists for use as medicaments
11/02/2005EP1246807B1 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
11/02/2005EP1242363B1 Cd45 inhibitors
11/02/2005EP1237902B1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase
11/02/2005EP1169244B1 Metering valve
11/02/2005EP1168923B1 Dna vaccination for treatment of autoimmune disease
11/02/2005EP1080095B1 Modulators of protein tyrosine phosphatases (ptpases)
11/02/2005EP1005493B1 Antiviral protease inhibitors
11/02/2005EP0901521B1 Antigenic modulation of cells
11/02/2005CN1692161A Treatment for asthma or allergies
11/02/2005CN1692156A Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
11/02/2005CN1692127A TACI antibodies and uses thereof
11/02/2005CN1692123A Compounds, compositions and methods for treatment of inflammatory diseases and conditions
11/02/2005CN1692120A Inhibitors of nucleoside phosphorylases and nucleosidases
11/02/2005CN1692115A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
11/02/2005CN1691957A 蛋白酶抑制剂 Protease inhibitors
11/02/2005CN1691945A Use of rapamycin for inhibiting of cell death
11/02/2005CN1690079A Polyethylene glycol-modified thymus peptide 1 derivatives
11/02/2005CN1225480C Anti CD52 monoclonal antibody, coding sequence and use thereof
11/02/2005CN1225479C Tumour necrosis factor antibody, preparing method and medicinal composition thereof
11/02/2005CN1225478C Embedded CD25-resisting monoclonal antibody and its coding sequence and application
11/02/2005CN1225273C Nutritious health care food and preparation process thereof
11/02/2005CN1225252C Process for preparing composition comprising medicinal herb extract for preventing and treating arthritis and composition thereof
11/02/2005CN1225249C Antivirus medicine for raising immunity and its preparation method
1 ... 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 ... 1172